- 专利标题： Process for making beta 3 agonists and intermediates
-
申请号： US17155982申请日： 2021-01-22
-
公开(公告)号： US11708371B2公开(公告)日： 2023-07-25
- 发明人: John Y. L. Chung , Kevin Campos , Edward Cleator , Robert F. Dunn , Andrew Gibson , R. Scott Hoerrner , Stephen Keen , Dave Lieberman , Zhuqing Liu , Joseph Lynch , Kevin M. Maloney , Feng Xu , Nobuyoshi Yasuda , Naoki Yoshikawa , Yong-Li Zhong
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 分案原申请号： US15057427 2016.03.01
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D403/12 ; C07D207/09 ; C07D263/06 ; A61K31/4196 ; A61K31/519
摘要：
The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.
公开/授权文献
- US20210221815A1 Process for Making Beta 3 Agonists and Intermediates 公开/授权日：2021-07-22
信息查询
